FMFangya Mao

Fangya Mao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fangya Mao has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Benefits and Harms of Immediate Versus Delayed Treatment of Cervical Intraepithelial Neoplasia Grade 2

    by Li C. Cheung, Fangya Mao, Greg Rydzak, Nicolas Wentzensen, Nancy E. Poitras, Thomas S. Lorey, Philip E. Castle

    Cervical intraepithelial neoplasia (CIN) grade 2 (CIN 2) is an equivocal diagnosis of cervical precancer, and appropriate management continues to be debated. To estimate the effect of immediate (by 6 months) versus delayed (after 6 months or no) treatment of CIN 2. Observational emulation of a target trial of immediate versus delayed treatment, using inverse probability weighting (IPW) to adjust for baseline factors. Routine cervical screening at Kaiser Permanente Northern California. 12 012 women with CIN 2 found on initial biopsy from 2017 to 2023. Immediate treatment (excision by 6 months after initial CIN 2 without interim surveillance by screening or colposcopy) versus delayed treatment (continued surveillance by screening or colposcopy, regardless of subsequent excision timing, or excision ≥6 months after initial CIN 2). 3-year probability of potentially unnecessary excision (less severe than CIN 2 [<CIN 2]), and 3-year risks for CIN grade 3 or more severe (CIN 3+) or invasive cervical cancer after initial CIN 2. Immediate treatment was associated with a higher 3-year probability of <CIN 2 on excision compared with delayed treatment (36.2% vs. 7.8%). The IPW-standardized 3-year risks for cancer (0.39% vs. 0.43%) and CIN 3+ (8.85% vs. 10.31%) were similar under the 2 management strategies. Lack of randomized assignment to interventions; cancer was rare. Immediate treatment did not reduce 3-year cancer risk compared with delayed treatment after CIN 2. Delaying treatment avoided some potentially unnecessary excisions but women with CIN 2 with immediate or delayed care were still at risk for cancer and required monitoring. Intramural Research Program of the National Institutes of Health National Cancer Institute.


  • Open Access

    Cessation of Betel Quid Chewing, Smoking, and Alcohol Drinking and Risk of Oral Precancer and Oral Cancer

    by Fangya Mao, Tseng-Cheng Chen, Kelly J. Yu, Li C. Cheung, Wan-Lun Hsu, Ming-Hsui Tsai, Chung-Jan Kang, Chih-Yen Chien, Chun-Hung Hua, Hsiu-Hsi Chen, et al.

    PURPOSE: To quantify risk reduction in oral precancer and cancer with time since cessation of betel quid chewing, smoking, and alcohol drinking. PATIENTS AND METHODS: We conducted a multicenter case-control study in Taiwan of patients with invasive oral cancer (n = 768), visual/clinical oral precancer (n = 1,998), and hospital-based controls (n = 717, recalibrated/reweighted to represent the Taiwan general population). Weighted logistic regression was used to evaluate associations of duration, intensity, and time since cessation of betel quid chewing without tobacco, smoking, and alcohol drinking (modeled using splines and categorically) with oral precancer and cancer risk versus controls. RESULTS: Risk of oral precancer increased with increased duration and intensity of chewing and smoking, and increased intensity of alcohol drinking. Risk of oral cancer increased with increased duration and intensity of chewing, increased duration of smoking, and increased intensity of alcohol drinking. For oral precancer, when compared with current users (defined as current users and individuals who quit for ≤2 years before study recruitment), odds ratios (ORs) for 10-year cessation of behaviors were as follows: chewing = 0.63 (bootstrap 95% CI, 0.43 to 0.83); smoking = 0.30 (95% CI, 0.18 to 0.41); and alcohol = 0.60 (95% CI, 0.34 to 0.86). Likewise, risk of oral cancer decreased with increasing time since cessation; ORs for 10-year cessation were as follows: chewing = 0.74 (95% CI, 0.44 to 1.05); smoking = 0.45 (95% CI, 0.22 to 0.67); and alcohol drinking = 0.55 (95% CI, 0.20 to 0.90). Adjusted population-attributable fractions show that cessation of chewing for ≥10 years would prevent an estimated 23.2% of oral precancers and 24.2% of oral cancers; cessation of smoking for ≥10 years would prevent 51.5% of oral precancers and 44.6% of cancers in Taiwan. CONCLUSION: Our findings support the potential for primary prevention of oral precancer and cancer through cessation of betel quid chewing (without tobacco), smoking, and alcohol drinking among current users.

  • Two-phase designs for cost-effective evaluation of cancer screening tests

    by Fangya Mao, Richard J Cook, Thomas Lorey, Nicolas Wentzensen, Li C Cheung

    Screening tests are crucial for detecting diseases at preclinical stages when timely intervention can prevent progression to more severe conditions. Advances in technology have facilitated developing screening tests based on novel markers, but evaluating their performance using biospecimens from large cohorts remains logistically complex and financially demanding. Two-phase designs offer a cost-effective solution by allowing inference when expensive marker measurements are collected on only a carefully selected subsample. While traditional two-phase designs have primarily targeted estimation of marker-outcome associations, they can effectively be extended to evaluate the clinical performance of a test, including estimation of positive predictive value (the risk in test positives) and complementary negative predictive value (the risk in test negatives). We propose a novel two-phase design for efficiently evaluating the risk-stratification utility of screening tests in distinguishing between high- and low-risk individuals for both current and future disease. Designed for use with biospecimens collected from screening studies, our methodology accommodates cohorts that include both pre-existing cases at an initial screening visit and new cases identified during follow-up. We demonstrate the efficiency gains of our proposed design compared to other subsampling schemes through simulation and illustrate its application in a motivating study evaluating the p16/ki-67 dual-stain test for managing human papillomavirus-positive women in cervical cancer screening. Data and stored biospecimen samples from Kaiser Permanente Northern California are used in this analysis.

  • Data-augmented multistate modeling for chronic disease processes using cross-sectional studies: application to HPV and cervical precancer

    by Fangya Mao, Nicole G Campos, Li C Cheung

    Summary: Understanding the population-level natural history of human papillomavirus (HPV) infection and cervical precancer is essential for informing effective prevention strategies. Multistate models provide a principled framework for characterizing disease progression by modeling transitions among discrete health states. However, intensity-based multistate analyses typically require longitudinal data, which are often costly and logistically difficult to obtain, whereas cross-sectional data are more widely available, particularly in resource-limited settings. We develop a semi-Markov multistate model that captures HPV infection dynamics and cervical precancer progression, including recurrent transitions between HPV-infected and uninfected states. To enable estimation from cross-sectional data, we propose a two-step approach that combines local cross-sectional observations with external information on transferable transition intensities. First, biologically driven transition intensities are estimated from external data under a transferability assumption. Second, these estimates are incorporated into an approximate likelihood to infer population-specific transition intensities shaped by local epidemiological and behavioral factors. Simulation studies and applications to 2 populations demonstrate the performance of the proposed method and its practical utility.

  • Multistate oral carcinogenesis—A prospective cohort study and a parallel case-control study in Taiwan

    by Cheng-Ping Wang, Kelly J. Yu, Tseng-Cheng Chen, Ming-Shui Tsai, Chung-Jan Kang, Chi-Yen Chien, Eric A. Engels, Chun-Hung Hua, Wan-Lun Hsu, Yih-Leong Chang, et al.


  • Open Access

    Two-phase biomarker studies for disease progression with multiple registries

    by Fangya Mao, Richard J Cook

    We consider the design and analysis of two-phase studies of the association between an expensive biomarker and disease progression when phase I data are obtained by pooling registries having different outcome-dependent recruitment schemes. We utilize two analysis methods, namely maximum-likelihood and inverse probability weighting (IPW), to handle missing covariates arising from a two-phase design. In the likelihood framework, we derive a class of residual-dependent designs for phase II sub-sampling from an observed data likelihood accounting for the phase I sampling plans used by the different registries. In the IPW approach, we derive and evaluate optimal stratified designs that approximate Neyman allocation. Simulation studies and an application to a motivating example demonstrate the finite sample improvements from the proposed designs over simple random sampling and standard stratified sampling schemes.


  • Two-phase designs with failure time processes subject to nonsusceptibility

    by Fangya Mao, Li C Cheung, Richard J Cook

    Epidemiological studies based on 2-phase designs help ensure efficient use of limited resources in situations where certain covariates are prohibitively expensive to measure for a full cohort. Typically, these designs involve 2 steps: In phase I, data on an outcome and inexpensive covariates are acquired, and in phase II, a subsample is chosen in which the costly variable of interest is measured. For right-censored data, 2-phase designs have been primarily based on the Cox model. We develop efficient 2-phase design strategies for settings involving a fraction of long-term survivors due to nonsusceptibility. Using mixture models accommodating a nonsusceptible fraction, we consider 3 regression frameworks, including (a) a logistic “cure” model, (b) a proportional hazards model for those who are susceptible, and (c) regression models for susceptibility and failure time in those susceptible. Importantly, we introduce a novel class of bivariate residual-dependent designs to address the unique challenges presented in scenario (c), which involves 2 parameters of interest. Extensive simulation studies demonstrate the superiority of our approach over various phase II subsampling schemes. We illustrate the method through applications to the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.


  • Two‐phase designs with current status data

    by Fangya Mao, Richard J. Cook

    We consider the design and analysis of two-phase studies aiming to assess the relation between a fixed (eg, genetic) marker and an event time under current status observation. We consider a common setting in which a phase I sample is comprised of a large cohort of individuals with outcome (ie, current status) data and a vector of inexpensive covariates. Stored biospecimens for individuals in the phase I sample can be assayed to record the marker of interest for individuals selected in a phase II sub-sample. The design challenge is then to select the phase II sub-sample in order to maximize the precision of the marker effect on the time of interest under a proportional hazards model. This problem has not been examined before for current status data and the role of the assessment time is highlighted. Inference based on likelihood and inverse probability weighted estimating functions are considered, with designs centered on score-based residuals, extreme current status observations, or stratified sampling schemes. Data from a registry of patients with psoriatic arthritis is used in an illustration where we study the risk of diabetes as a comorbidity.


  • Spatial Dependence Modeling of Latent Susceptibility and Time to Joint Damage in Psoriatic Arthritis

    by Fangya Mao, Richard J. Cook

    Important scientific insights into chronic diseases affecting several organ systems can be gained from modeling spatial dependence of sites experiencing damage progression. We describe models and methods for studying spatial dependence of joint damage in psoriatic arthritis (PsA). Since a large number of joints may remain unaffected even among individuals with a long disease history, spatial dependence is first modeled in latent joint-specific indicators of susceptibility. Among susceptible joints, a Gaussian copula is adopted for dependence modeling of times to damage. Likelihood and composite likelihoods are developed for settings, where individuals are under intermittent observation and progression times are subject to type K interval censoring. Two-stage estimation procedures help mitigate the computational burden arising when a large number of processes (i.e., joints) are under consideration. Simulation studies confirm that the proposed methods provide valid inference, and an application to the motivating data from the University of Toronto Psoriatic Arthritis Clinic yields important insights which can help physicians distinguish PsA from arthritic conditions with different dependence patterns.